Press Releases
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
April 15, 2025
KYOTO, Japan , April 15, 2025 /PRNewswire/ -- Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan ; Chief Executive Officer: Akifumi Morinaka ) has annou...
